Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Vorinostat × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 11 Brain Neoplasms 11 Neuroblastoma 10 Gliosarcoma 6 Astrocytoma 5 Glioma 4 Oligodendroglioma 3 Medulloblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lung Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Dendritic Cell Sarcoma, Interdigitating 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Sezary Syndrome 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1

Interventions

Temozolomide 2 vorasidenib 1 pembrolizumab 1 pamiparib 1 cixutumumab 1 Vorinostat 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Antibodies, Monoclonal 1 Aminolevulinic Acid 1 Amifostine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03561259 2023-02-16

OPTIMUM

Jubilant DraxImage Inc.

Phase 2 Unknown

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡